Literature DB >> 70274

Raynaud's phenomenon as a side effect of chemotherapy with vinblastine and bleomycin for testicular carcinoma.

C Teutsch, A Lipton, H A Harvey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 70274

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  7 in total

Review 1.  Comparative tolerability of chemotherapy regimens for germ cell cancer.

Authors:  S Culine; J P Droz
Journal:  Drug Saf       Date:  2000-05       Impact factor: 5.606

Review 2.  Zebrafish Germ Cell Tumors.

Authors:  Angelica Sanchez; James F Amatruda
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

Review 3.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

4.  Limb ischemia caused by small artery disease.

Authors:  J M Porter; L M Taylor
Journal:  World J Surg       Date:  1983-05       Impact factor: 3.352

5.  Hemolytic uremic syndrome in a patient on cis-platinum, vinblastine and bleomycin.

Authors:  J van der Meer; E G de Vries; R Vriesendorp; P H Willemse; A J Donker; J G Aalders
Journal:  J Cancer Res Clin Oncol       Date:  1985       Impact factor: 4.553

6.  Severe vascular toxicity associated with vinblastine, bleomycin, and cisplatin chemotherapy.

Authors:  B L Samuels; N J Vogelzang; B J Kennedy
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

7.  Observational study of prevalence of long-term Raynaud-like phenomena and neurological side effects in testicular cancer survivors.

Authors:  Marianne Brydøy; Jan Oldenburg; Olbjørn Klepp; Roy M Bremnes; Erik A Wist; Tore Wentzel-Larsen; Erik R Hauge; Olav Dahl; Sophie D Fosså
Journal:  J Natl Cancer Inst       Date:  2009-12-16       Impact factor: 13.506
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.